We focus on the most likely growth clusters in 2020s in digitalization, healthcare/demographics and sustainables/renewables.

We invest in high quality biotech companies with regulatory tailwind from the FDA. The primary focus of the fund is companies with Breakthrough designation in cancer, immunooncology and genetherapy

Advice Capital Global invests in attractive companies across sector, geography and size.   We try to take advantage of temporarily inefficient markets. First of all, temporarily inefficient markets can be exploited when the market falls.